Seeking Alpha

New research shows heart stents' advantage over medicine, exercise, and a diet plan fades over...

New research shows heart stents' advantage over medicine, exercise, and a diet plan fades over time. This could pose a problem for stent manufacturers, notably Johnson & Johnson (JNJ) and Boston Scientific (BSX) - who expect up to $5B in sales next year.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs